The Impact of Reoperations Following Bariatric Surgery on Mid-term Outcomes
- PMID: 36826677
- PMCID: PMC10079741
- DOI: 10.1007/s11695-023-06519-0
The Impact of Reoperations Following Bariatric Surgery on Mid-term Outcomes
Abstract
Purpose: With the obesity epidemic, the number of bariatric procedures is increasing, and although considered relatively safe, major postoperative complications still occur. In cancer surgery, major complications such as reoperations have been associated with deteriorated mid/long-term outcomes. In obesity surgery, the effects of reoperations on postoperative weight loss and associated comorbidities remain unclear. The aim of this study was to assess mid-term weight loss and comorbidities following early reoperations in obesity surgery.
Methods: A population-based cohort study was performed within the Dutch Audit for Treatment of Obesity (DATO), including all patients that underwent a primary gastric bypass procedure or sleeve gastrectomy. Follow-up data was collected up until 5 years postoperatively on percentage total weight loss (%TWL) and comorbidities.
Results: A total of 40,640 patients underwent a gastric bypass procedure or sleeve gastrectomy between 2015 and 2018. Within this cohort, 709 patients (1.7%) suffered a major complication requiring reoperation within 30 days. %TWL at 24 months was 33.1 ± 9.2 in the overall population, versus 32.9 ± 8.7 in the patients who underwent a reoperation (p=0.813). Both analysis per year and Cox regression techniques revealed no differences in long-term follow-up regarding percentage TLW, and weight loss success rates (%TWL>20%) in patients who underwent a reoperation compared to patients without reoperation. At 5 years, the availability of follow-up data was low. No differences were observed in the remission of comorbidities.
Discussion: Major complications requiring reoperation within 30 days of gastric bypass surgery or sleeve gastrectomy did not affect long-term outcomes with regard to weight loss or remission of comorbidities.
Keywords: Comorbidities; Mid-term follow-up; Percentage total weight loss; Reoperations.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.JAMA. 2018 Jan 16;319(3):255-265. doi: 10.1001/jama.2017.20897. JAMA. 2018. PMID: 29340679 Free PMC article. Clinical Trial.
-
Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.Int J Surg. 2020 Apr;76:101-110. doi: 10.1016/j.ijsu.2020.02.035. Epub 2020 Mar 6. Int J Surg. 2020. PMID: 32151750
-
Converting a Sleeve Gastrectomy to a Gastric Bypass for Weight Loss Failure-Is It Worth It?Obes Surg. 2018 Feb;28(2):364-368. doi: 10.1007/s11695-017-2856-6. Obes Surg. 2018. PMID: 28891022
-
Reoperations after sleeve gastrectomy: a dual academic institutional experience.Surg Obes Relat Dis. 2022 May;18(5):641-649. doi: 10.1016/j.soard.2022.01.015. Epub 2022 Jan 21. Surg Obes Relat Dis. 2022. PMID: 35181221
-
Effectiveness of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity in achieving weight loss outcomes.Int J Surg. 2019 Oct;70:35-43. doi: 10.1016/j.ijsu.2019.08.010. Epub 2019 Aug 10. Int J Surg. 2019. PMID: 31408745
Cited by
-
Post laparoscopic sleeve gastrectomy portal vein thrombosis with venous mesenteric ischemia: a case report with literature review.J Surg Case Rep. 2024 Aug 21;2024(8):rjae462. doi: 10.1093/jscr/rjae462. eCollection 2024 Aug. J Surg Case Rep. 2024. PMID: 39171196 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical